Literature DB >> 8769907

Physicians, pharmaceutical sales representatives, and the cost of prescribing.

T S Caudill1, M S Johnson, E C Rich, W P McKinney.   

Abstract

OBJECTIVE: To evaluate the influence of primary care physicians' attitudes toward and use of information provided by pharmaceutical representatives on prescribing costs in ambulatory practice.
DESIGN: A mailed questionnaire collected information about physician demographic and practice characteristics and attitudes toward and use of information provided by pharmaceutical representatives. PARTICIPANTS: Kentucky physicians practicing primary care adult medicine (family medicine, general practice, general medicine; n = 1603). MAIN OUTCOME MEASURE: Relative cost of prescribing, based on physician responses to treatment choices for ambulatory clinical scenarios in primary care. A multivariable regression model assessed predictive relationships between independent variables and prescription costs.
RESULTS: Four hundred forty-six returned questionnaires were suitable for analysis. No significant differences were noted in age, gender, days worked per week, or years since graduation between responders and a sample of nonresponders. A significant positive correlation was found between physician cost of prescribing and perceived credibility, availability, applicability, and use of information provided by pharmaceutical representatives (P < .01, Pearson's Product-Moment Correlation Coefficient). Physicians in academic or hospital-based practice settings had significantly lower prescribing costs than physicians in nonacademic and nonhospital practices (P = .001, analysis of variance). Frequency of use of information provided by pharmaceutical representatives (P = .01, multiple linear regression) and the group practice setting (P = .02, multiple linear regression) remained significant, independent positive predictors of cost in the multivariable regression model.
CONCLUSIONS: Frequency of use of information provided by pharmaceutical representatives and the group practice, nonacademic and nonhospital setting may be associated with increased primary care physician prescribing costs.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1996        PMID: 8769907     DOI: 10.1001/archfami.5.4.201

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  33 in total

1.  Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.

Authors:  James S Yeh; Kirsten E Austad; Jessica M Franklin; Susan Chimonas; Eric G Campbell; Jerry Avorn; Aaron S Kesselheim
Journal:  J Grad Med Educ       Date:  2015-12

2.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

3.  Impact of an evidence-based computerized decision support system on primary care prescription costs.

Authors:  S Troy McMullin; Thomas P Lonergan; Charles S Rynearson; Thomas D Doerr; Paul A Veregge; Edward S Scanlan
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

4.  Promotional methods used by representatives of drug companies: a prospective survey in general practice.

Authors:  Jesper Schramm; Morten Andersen; Kirstin Vach; Jakob Kragstrup; Jens Peter Kampmann; Jens Søndergaard
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

5.  General practitioners and pharmaceutical sales representatives: quality improvement research.

Authors:  Geoffrey Spurling; Peter Mansfield
Journal:  Qual Saf Health Care       Date:  2007-08

6.  Influencing prescribing patterns.

Authors:  P Huston; N R Campbell
Journal:  Can Fam Physician       Date:  1998-02       Impact factor: 3.275

7.  Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.

Authors:  G Guyatt
Journal:  Can Fam Physician       Date:  1997-11       Impact factor: 3.275

8.  Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.

Authors:  Peter A Ubel; Christopher Jepson; David A Asch
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

9.  Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.

Authors:  C Watkins; I Harvey; P Carthy; L Moore; E Robinson; R Brawn
Journal:  Qual Saf Health Care       Date:  2003-02

10.  Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions.

Authors:  Spencer D Dorn; Joel F Farley; Richard A Hansen; Nilay D Shah; Robert S Sandler
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.